Literature DB >> 2845707

Comparison of low molecular weight heparin vs. unfractionated heparin in gynecological surgery.

E Borstad1, K Urdal, G Handeland, U Abildgaard.   

Abstract

In a double-blind, randomized trial, the antithrombotic effect and haemorrhagic complications of low molecular weight heparin (LMWH) (Heparin fragment 2165, KabiVitrum) and unfractionated heparin (UH) were compared. LMWH (5000 anti-XaU) was injected every 24 h, UH (5000 IU) every 12 h; both drugs by subcutaneous injection. During 1984-85, 215 patients were examined clinically and by plethysmography. Venography was performed whenever DVT was suspected. None of the patients proved to have DVT. Bleeding complications were found in 54% of the cases. The LMWH group had a statistically significant predominance of bleeding complications as reflected by wound haematomas (p = 0.02) and the number of blood transfusions (p = 0.02). The heparin concentration was higher in the LMWH group (mean 0.13 IU/ml) than in the UH group (mean 0.13 IU/ml) measured 2 h after the injection. In the doses administered, LMWH and UH seem effective in the prevention of thrombosis. The increased bleeding tendency in the LMWH group probably was a consequence of the to high dosage.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845707     DOI: 10.3109/00016348809004178

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  7 in total

1.  Venous thromboembolism in women undergoing pelvic reconstructive surgery with mechanical prophylaxis alone.

Authors:  T Ignacio Montoya; Edgar L Leclaire; Susan H Oakley; Andrea K Crane; Alexandra Mcpencow; Sara Cichowski; David D Rahn
Journal:  Int Urogynecol J       Date:  2014-02-07       Impact factor: 2.894

Review 2.  Prophylactic and therapeutic anticoagulation for thrombosis: major issues in oncology.

Authors:  Marc Carrier; Agnes Y Y Lee
Journal:  Nat Clin Pract Oncol       Date:  2008-10-28

3.  Low molecular weight heparin in prevention of perioperative thrombosis.

Authors:  A Leizorovicz; M C Haugh; F R Chapuis; M M Samama; J P Boissel
Journal:  BMJ       Date:  1992-10-17

4.  American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.

Authors:  David R Anderson; Gian Paolo Morgano; Carole Bennett; Francesco Dentali; Charles W Francis; David A Garcia; Susan R Kahn; Maryam Rahman; Anita Rajasekhar; Frederick B Rogers; Maureen A Smythe; Kari A O Tikkinen; Adolph J Yates; Tejan Baldeh; Sara Balduzzi; Jan L Brożek; Itziar Etxeandia- Ikobaltzeta; Herman Johal; Ignacio Neumann; Wojtek Wiercioch; Juan José Yepes-Nuñez; Holger J Schünemann; Philipp Dahm
Journal:  Blood Adv       Date:  2019-12-10

Review 5.  Efficacy of intermittent pneumatic compression for venous thromboembolism prophylaxis in patients undergoing gynecologic surgery: A systematic review and meta-analysis.

Authors:  Jian-Ping Feng; Yu-Ting Xiong; Zi-Qi Fan; Li-Jie Yan; Jing-Yun Wang; Ze-Juan Gu
Journal:  Oncotarget       Date:  2017-03-21

Review 6.  Anticoagulation for perioperative thromboprophylaxis in people with cancer.

Authors:  Charbel F Matar; Lara A Kahale; Maram B Hakoum; Ibrahim G Tsolakian; Itziar Etxeandia-Ikobaltzeta; Victor Ed Yosuico; Irene Terrenato; Francesca Sperati; Maddalena Barba; Holger Schünemann; Elie A Akl
Journal:  Cochrane Database Syst Rev       Date:  2018-07-11

7.  Comparison of Efficacy and Safety of Two Different Enoxaparin Products in Prevention of Venous Thromboembolism Following Major Obstetric-gynecological Surgeries: An Open-label Randomized Clinical Trial.

Authors:  Manoochehr Abdolvand; Ashraf Aleyasin; Mohammad Reza Javadi; Mohammad Solduzian; Seyed Hossein Hosseini; Zohreh Ziaei; Samira Samira; Kheirollah Gholami
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.